Shilpa Medicare Ltd. (SHILPAMED) Share Price Hits Fresh 52-Week High
- August 24, 2026
- Posted by: Harsh Piplani
- Category: News
Shilpa Medicare Ltd. Share Price is in focus after the stock rose to Rs 846.6, up 3.94% from the previous close of Rs 814.5, and matched a fresh 52-week high of Rs 849.2. The company’s market capitalisation now stands at Rs 15,930.14 crore. Shilpa Medicare Ltd. Share Price Today reflects a clear price event, but the supplied data does not establish a company-specific catalyst. What the data does confirm is that the stock has moved above its earlier yearly range and is drawing attention as Shilpa Medicare Stock News today. Univest is tracking the move as part of its live market coverage, with the focus now on valuation, earnings quality and sector positioning rather than a guessed reason for the rise.
The session opened at Rs 820.85, moved between Rs 811.05 and Rs 849.2, and closed the measured data point near the day’s high. Turnover stood at Rs 3.99 crore. For readers following Shilpa Medicare Share Price Live, the key point is simple: the stock has recorded a fresh 52-week high, and the supplied facts are sufficient to confirm the event without adding an unsupported trigger. Shilpa Medicare Share Price update coverage on Univest therefore centres on observed price action, company fundamentals and the Healthcare sector backdrop.
Shilpa Medicare Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 846.6 |
| Previous Close | Rs 814.5 |
| Today's Move | +Rs 32.1 (+3.94%) |
| Open | Rs 820.85 |
| High | Rs 849.2 |
| Low | Rs 811.05 |
| Turnover | Rs 3.99 crore |
| Market Capitalisation | Rs 15,930.14 crore |
Shilpa Medicare Ltd. (SHILPAMED) traded at Rs 846.6 versus the previous close of Rs 814.5, a rise of 3.94%. The stock opened at Rs 820.85, reached a high of Rs 849.2 and touched a low of Rs 811.05.
Shilpa Medicare Ltd. Share Price Today shows a gain of Rs 32.1 over the previous close, which translates into a 3.94% rise. The stock opened at Rs 820.85, printed a low of Rs 811.05 and reached Rs 849.2, which is also the reported 52-week high. That means the day’s high and the yearly high were the same level in the supplied data, a factual detail that makes this Shilpa Medicare Share Price move relevant for event-driven screens. Turnover of Rs 3.99 crore gives a value-based measure of trading for the session, and the stock ended the observed move near the top of the range. In plain terms, the data confirms a fresh 52-week high for Shilpa Medicare Share Price without assigning a reason that is not in the record. Univest is using that distinction carefully, because verified price facts matter more than assumptions in Shilpa Medicare Stock News.
This price action also places Shilpa Medicare Share Price on watchlists for 52 Week High Stocks, but only as a factual event marker. The move is significant because it shows the market has printed a new yearly reference point, and that can change how investors frame Shilpa Medicare Share Price Today versus recent history. The next sections focus on whether the numbers behind the stock support that move.
Shilpa Medicare Ltd. (SHILPAMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 15,930.14 crore |
| P/E Ratio | 53.58x |
| P/B Ratio | 5.93x |
| ROE | 9.82% |
| ROCE | 11.43% |
| EPS | Rs 15.2 |
| Book Value Per Share | Rs 137.34 |
| Dividend Yield | 0.07% |
Shilpa Medicare Ltd. (SHILPAMED) fundamental metrics show P/E 53.58x, P/B 5.93x, ROE 9.82%, ROCE 11.43%. These figures provide context only and are not a buy or sell signal.
Shilpa Medicare Ltd. has a market capitalisation of Rs 15930.14 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 53.58x, P/B at 5.93x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.82% and ROCE of 11.43%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 15.2, book value per share of Rs 137.34, dividend yield of 0.07%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.84x, median ROE of 11.81%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 53.58x |
| Benchmark Median P/E | 30.84x |
| Benchmark Average P/E | 46.29x |
| Benchmark P/E Range | 2.94x to 689.27x |
| Company P/B Ratio | 5.93x |
| Benchmark Median P/B | 2.57x |
| Company ROE | 9.82% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 11.43% |
| Benchmark Median ROCE | 13.68% |
| Company Market Capitalisation | Rs 15,930.14 crore |
| Benchmark Median Market Cap | Rs 506.13 crore |
Shilpa Medicare Ltd. (SHILPAMED) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 53.58x, which is above the benchmark median of 30.84x, a difference of +73.74%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Shilpa Medicare Ltd. (SHILPAMED) has a ROE of 9.82%, which is below the benchmark median of 11.81%, a difference of -16.85%. Shilpa Medicare Ltd. (SHILPAMED) has a ROCE of 11.43%, which is below the benchmark median of 13.68%, a difference of -16.45%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Natco Pharma Ltd. | NATCOPHARM | 15,806.45 | 13.81 | 1.69 | 27.98 | 32.85 |
| Alembic Pharmaceuticals Ltd. | APLLTD | 16,128 | 23.26 | 2.76 | 12.35 | 11.74 |
| Concord Biotech Ltd. | CONCORDBIO | 16,417.42 | 59.62 | 7.92 | 13.54 | 18.04 |
| Glenmark Life Sciences Ltd. | ALIVUS | 16,556.96 | 27.46 | 4.75 | 18.41 | 24.61 |
| Marksans Pharma Ltd. | MARKSANS | 14,557.89 | 28.17 | 4.58 | 15.31 | 21.1 |
Shilpa Medicare Ltd. (SHILPAMED) has a P/E ratio of 53.58x compared with the displayed peer median of 27.46x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.82% compares with a peer median of 15.31% across the companies shown in the table. ROCE stood at 11.43% versus the displayed peer median of 21.1%, providing a capital-efficiency comparison. Shilpa Medicare Ltd. (SHILPAMED) has a market capitalisation of Rs 15,930.14 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Shilpa Medicare Ltd.
- Shilpa Medicare Share Price rose 3.94% to Rs 846.6 and matched a fresh 52-week high of Rs 849.2.
- The reported day range was Rs 811.05 to Rs 849.2, with opening price at Rs 820.85.
- Market capitalisation stands at Rs 15,930.14 crore, which is above the industry median of Rs 506.13 crore.
- P/E is 53.58 and P/B is 5.93, both above the same-industry median and average in the supplied benchmark.
- Revenue and net profit both increased in the supplied quarterly series from Jun 2025 to Jun 2026.
About Shilpa Medicare Ltd.
Shilpa Medicare Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. In the supplied dataset, those are the only company-description facts available, so Shilpa Medicare Share Price analysis here stays anchored to the verified sector classification, listed valuation ratios, recent financial results and benchmark comparisons. Univest uses that same fact-first approach across Shilpa Medicare Stock News and Shilpa Medicare Company News.
Track Shilpa Medicare Ltd. Share Price on Univest
Use Shilpa Medicare Ltd. (SHILPAMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Shilpa Medicare Ltd. Share Price on Univest for live price updates, market cap, financial ratios, shareholding pattern, 52-week levels, peer comparison and company insights. Shilpa Medicare Share Price Today, Shilpa Medicare Stock News and Shilpa Medicare Share Price Live pages on Univest are built to keep the data in one place for quick review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Shilpa Medicare Ltd. Share Price hit a fresh 52-week high?
Ans. The supplied data confirms Shilpa Medicare Ltd. Share Price reached Rs 849.2, a fresh 52-week high, but it does not establish a company-specific catalyst. Univest is reporting the verified price event and associated market cap of Rs 15,930.14 crore.
What is Shilpa Medicare Ltd. Share Price today?
Ans. Shilpa Medicare Ltd. Share Price is Rs 846.6 in the supplied update. It is Rs 32.1 higher than the previous close of Rs 814.5 and reflects a 3.94% rise during the session.
What was the day’s high for Shilpa Medicare Share Price?
Ans. The day’s high for Shilpa Medicare Share Price was Rs 849.2, which is also the reported fresh 52-week high. The session low was Rs 811.05, and the stock opened at Rs 820.85.
How does Shilpa Medicare Ltd. Share Price compare with valuation benchmarks?
Ans. Shilpa Medicare Ltd. Share Price is linked to a P/E of 53.58 and a P/B of 5.93. Both are above the same-industry median and average in the supplied Healthcare benchmark of 204 companies.
What do the latest fundamentals show for Shilpa Medicare Ltd.?
Ans. The latest supplied fundamentals show EPS of Rs 15.2, book value of Rs 137.34 and dividend yield of 0.07. Revenue and net profit also increased in the Jun 2025 to Jun 2026 quarterly series.
How does Shilpa Medicare Ltd. compare with its peers?
Ans. Shilpa Medicare Ltd. has a market cap of Rs 15,930.14 crore, which is close to Natco Pharma and Alembic Pharmaceuticals in the supplied peer set. Its P/E is higher than most listed peers shown.
